taiba ME Group HQ in Dubai (UAE) & Riyadh (KSA), with regional offices throughout the MENA region.Established 40 years ago, taiba is committed to helping rare disease patients across the GCC and beyond, within the Middle East and Africa. The group operates multiple subsidiaries, multinational pharmaceutical distribution, and has recently launched Menagen, a state-of-the-art production facility focused on producing and commercializing niche innovative and hard-to-make medications. 

taiba rare is the leading independent global commercialization partner. We are at BIO to discuss:

• Commercialization partnerships in the Middle East North Africa , Turkey.

• In-licensing enablement

• Partnerships for assets approaching LOE

• Direct-to-patient models